Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Group B streptococcus and respiratory syncytial virus are leading causes of infant morbidity and mortality worldwide. No licensed vaccines are available for either disease, but vaccines for both are under development. Severe respiratory syncytial virus disease can be prevented by passively administered antibody. The presence of maternal IgG antibody specific to respiratory syncytial virus is associated with reduced prevalence and severity of respiratory syncytial virus disease in the first few weeks of life, whereas maternal serotype-specific anticapsular antibody is associated with protection against both early-onset and late-onset group B streptococcus disease. Therefore, vaccination in pregnancy might protect infants against both diseases. This report describes what is known about immune protection against group B streptococcus and respiratory syncytial virus, identifies knowledge gaps regarding the immunobiology of both diseases, and aims to prioritise research directions in maternal immunisation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739
Edmond, K. M., Kortsalioudaki, C., Scott, S., Schrag, S. J., Zaidi, A. K., Cousens, S., & Heath, P. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61651-6 · Cited by 600
Self-citationInfluenza vaccination of pregnant women and protection of their infants
Madhi, S. A., Cutland, C. L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., Adrian, P. V., van Niekerk, N., Treurnicht, F., Ortiz, J. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401480 · Cited by 556
Self-citationLadhani, S. N., Andrews, N. J., Southern, J., Jones, C. E., Amirthalingam, G., Waight, P. A., England, A., Matheson, M., Bai, X., Findlow, H., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ695 · Cited by 180
Self-citation; on behalf of the neonatal infections estimation team, Seale, A. C., Blencowe, H., Zaidi, A., Ganatra, H., Syed, S., Engmann, C., Newton, C. R., Vergnano, S., Stoll, B. J., et al. (2013) · Pediatric Research · doi:10.1038/pr.2013.207 · Cited by 159
Okoko, B. J., Wesumperuma, L. H., Ota, M. O. C., Pinder, M., Banya, W., Gomez, S. F., McAdam, K. P. J., & Hart, A. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/322808 · Cited by 121
van den Berg, J. P., Westerbeek, E. A. M., Berbers, G. A. M., van Gageldonk, P. G. M., van der Klis, F. R. M., & van Elburg, R. M. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181dc4f77 · Cited by 112
Cited by
Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology
Shabayek, S., & Spellerberg, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00437 · Cited by 291
Vaccine Safety: Myths and Misinformation
Geoghegan, S., O’Callaghan, K. P., & Offit, P. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00372 · Cited by 275
“In a large Danish cohort study comprising 805,206 children born between 1990 and 2001 no adverse associations were observed between an increasing number of vaccinations and hospitalizations with non-vaccine-targeted infections (Hviid et al., 2005).”
BackgroundWilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
“Interestingly, on subclass analysis, the reduced transfer seen in premature and low birth weight infants has been shown to be specific to IgG1 and IgG2, which may in part explain the higher susceptibility of premature infants to infections caused by polysaccharide-encapsulated pathogens which predominantly elicit IgG2…”
InfluentialSelf-citationMcCormack, S., Thompson, C., Nolan, M., Imcha, M., Dee, A., Saunders, J., & Philip, R. K. (2024) · Immunity, Inflammation and Disease · doi:10.1002/iid3.1257 · Cited by 32
Metadata
- Authors
- Heath, P. T., Culley, F. J., Jones, C. E., Kampmann, B., Le Doare, K., Nunes, M. C., Sadarangani, M., Chaudhry, Z., Baker, C. J., & Openshaw, P. J. M.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 17
- Issue
- 7
- Pages
- e223-e234
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2607148717
- Cited by
- 89
- References
- 11
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. https://app.cochat.ai/papers/10.1016/s1473-3099(17)30232-3
- The paper
- Heath, P. T., Culley, F. J., Jones, C. E., Kampmann, B., Le Doare, K., Nunes, M. C., Sadarangani, M., Chaudhry, Z., Baker, C. J., & Openshaw, P. J. M. (2017). Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(17)30232-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.